A randomized, placebo-controlled, double-blind study on the effects of (−)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects
Randomized, double-blind placebo-controlled trial in people with hypertriglyceridemia. The study reported preliminary favorable effects on glycemic homeostasis, lipid profile, and systemic inflammation, with parallel in vitro findings suggesting pathway-specific rather than generic antioxidant effects.